Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide pens use a click-based delivery system that measures doses in increments of 0.25mg, with most patients beginning at one click weekly. Understanding this dosing method helps you feel confident using your medication and tracking your progress. PlexusDx provides compounded semaglutide injection with personalized dose guidance based on your genetics and health profile.

What Does One Click Mean on a Semaglutide Pen?

A single click on a semaglutide injection pen advances the dose dial and delivers 0.25mg of medication through the needle. This standardized mechanical design removes guesswork and ensures consistent dosing across all patients. The click-and-lock system prevents accidental double-dosing and makes the injection process straightforward for people managing their weight at home.

The pen's rotary mechanism is calibrated by pharmaceutical manufacturers to dispense exact amounts with each audible and tactile click. After you hear and feel the click, you hold the needle in place for three to ten seconds to allow the full dose to enter your subcutaneous tissue. This simple protocol has become the gold standard in GLP-1 therapy because it combines accuracy with ease of use.

Starting Dose: Why 0.25mg Is the First Click

Medical guidelines recommend beginning semaglutide at 0.25mg once weekly to allow your body to adapt and minimize gastrointestinal side effects like nausea. One click on the pen delivers this starting amount, which typically produces mild appetite suppression and modest weight reduction during the first four weeks. Clinical data shows that gradual introduction at this dose level leads to better long-term tolerability and compliance.

Your healthcare provider may adjust your dose progression based on how your body responds. Some patients remain at 0.25mg for two to four weeks, while others move to the next dose level (0.5mg, or two clicks) after one week. PlexusDx personalizes your escalation timeline using your Precision Peptide Genetic Test results, which identify how your GLP-1 and GIPR pathways function at the genetic level.

The Dose Escalation Schedule: From Clicks to Maintenance

A standard semaglutide escalation follows a four-week progression: week one at 0.25mg (one click), week two through four at 0.5mg (two clicks), then advancing to 1.0mg (four clicks) in week five if tolerated, and finally reaching 2.0mg (eight clicks) by week nine. However, this timeline is not one-size-fits-all—some patients benefit from staying at lower doses longer, while others advance faster without side effects. Your genetics, metabolism, and appetite response all influence the optimal pace for your dose increases.

PlexusDx emphasizes that your dose may increase over time, but your price will not. Semaglutide injection begins at $149 per month regardless of whether you are taking one click or eight clicks. This flat-rate model removes the financial barrier to reaching your therapeutic dose and ensures you never delay treatment escalation due to cost concerns.

How PlexusDx Personalizes Your Semaglutide Dosing

Beyond the standard click schedule, PlexusDx uses the Precision Peptide Genetic Test to map 49 peptides across 14 biological pathways and provide 150+ genetic insights into your weight loss potential. Key variants in your GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) reveal whether you are a strong, moderate, or slower responder to GLP-1 therapy. This genetic roadmap allows your PlexusDx provider to tailor your starting dose, escalation speed, and maintenance level to your unique physiology.

Patients with genetic predispositions to rapid GLP-1 receptor activation may thrive on lower maintenance doses, reducing unnecessary side effects and cost. Conversely, those with variants associated with slower peptide pathway signaling might benefit from earlier dose increases or longer escalation periods. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment and transforms dosing from a one-size-fits-all protocol into a precision medicine approach.

What to Expect at Each Dose Level

At 0.25mg (one click), most patients experience mild appetite reduction and may notice slight nausea or digestive changes during the first few days. Weight loss during week one typically ranges from zero to two pounds as your body adjusts to the medication. Appetite suppression intensifies by day three or four, with most people naturally eating smaller portions without conscious restriction.

By 0.5mg (two clicks) in week two, appetite control becomes more pronounced and consistent, with average weekly weight loss of one to three pounds. At 1.0mg (four clicks) and above, appetite suppression reaches therapeutic levels, and weekly weight loss often accelerates to two to four pounds per week for eligible patients. These outcomes vary based on your genetic peptide pathways, diet quality, and exercise habits—all factors PlexusDx considers in your personalized treatment plan.

Common Questions About the Click Method

Many patients ask whether they can take multiple clicks at once to speed up dosing. The answer is no—the click method is designed to deliver one dose per week, and taking extra clicks in a single injection increases side effects without improving weight loss outcomes. Your healthcare provider will guide you through the weekly injection schedule and explain why consistent, measured increases work better than aggressive dosing.

If you miss a dose or accidentally click twice, contact PlexusDx immediately for guidance. Missing one weekly injection typically just means a one-week delay in your progression; accidentally taking a double dose may cause temporary nausea but is not dangerous, though it should be reported to your provider. Keeping a simple injection log helps you track which click number you took each week and prevents confusion.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many clicks equal 0.25mg of semaglutide?

One click on a semaglutide injection pen delivers 0.25mg. This is the standard starting dose for GLP-1 therapy and is taken once weekly. PlexusDx pens use the same click-based dosing system to ensure precise, consistent delivery every time you inject.

What is the typical dose progression schedule for semaglutide?

Standard escalation begins at 0.25mg (one click) for week one, increases to 0.5mg (two clicks) for weeks two through four, then advances to 1.0mg (four clicks) in week five and 2.0mg (eight clicks) by week nine. However, PlexusDx personalizes this timeline using your Precision Peptide Genetic Test results to optimize your individual response and minimize side effects.

Does the price of PlexusDx semaglutide increase with higher doses?

No. PlexusDx semaglutide injection starts at $149 per month and remains flat regardless of your dose level—whether you take one click or eight clicks. This pricing model ensures your dose can increase to therapeutic levels without escalating costs, removing financial barriers to optimal treatment.

What side effects should I expect when I increase my dose?

Mild nausea, reduced appetite, and occasional digestive changes are common during dose increases and usually resolve within three to seven days. Severe side effects are rare when doses increase gradually on the standard weekly schedule. If you experience persistent vomiting, severe abdominal pain, or unusual symptoms, contact PlexusDx immediately.

How does the Precision Peptide Genetic Test affect my dosing plan?

The Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide. This genetic information allows your PlexusDx provider to customize your starting dose, escalation pace, and maintenance level for faster results and fewer side effects. The test costs $99 after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves